The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic
- 23 March 2021
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Allergy and Clinical Immunology
- Vol. 21 (3), 245-251
- https://doi.org/10.1097/aci.0000000000000738
Abstract
Purpose of review Data regarding the effects of coronavirus disease 2019 (COVID-19) on host–microbiome alteration and subsequent effects on susceptibility and clinical course of COVID-19, especially in atopic patients, are currently limited. Here, we review the studies regarding the microbiome of atopic patients with other respiratory infections and discuss the potential role of probiotics as therapeutic targets for COVID-19 to decrease its susceptibility and severity of COVID-19. Recent findings Respiratory tract virus infection affects the gut and airway microbiome structures and host's immune function. Diverse factors in atopic diseases affect the airway and gut microbiome structures, which are expected to negatively influence host health. However, response to respiratory virus infection in atopic hosts depends on the preexisting microbiome and immune responses. This may explain the inconclusiveness of the effects of COVID-19 on the susceptibility, morbidity, and mortality of patients with atopic diseases. Beneficial probiotics may be a therapeutic adjuvant in COVID-19 infection as the beneficial microbiome can decrease the viral load in the early phase of respiratory virus infection and improve the morbidity and mortality. Summary Application of probiotics can be a potential adjuvant treatment in respiratory virus infection to improve host immune responses and disturbed microbiome structures in atopic patients. Further related studies involving COVID-19 are warranted in near future.Keywords
This publication has 54 references indexed in Scilit:
- MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces CommensalismImmunity, 2015
- Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy IndividualsmBio, 2015
- Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe AsthmaPLOS ONE, 2014
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory TractAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthmaJournal of Allergy and Clinical Immunology, 2011
- Different inflammatory phenotypes in adults and children with acute asthmaEuropean Respiratory Journal, 2011
- Role of viral respiratory infections in asthma and asthma exacerbationsThe Lancet, 2010
- Disordered Microbial Communities in Asthmatic AirwaysPLOS ONE, 2010
- The Human Microbiome ProjectNature, 2007